ClinicalTrials.Veeva

Menu

Positive Predictive Value (PPV) of Pseudomonas Aeruginosa

M

MolecuLight

Status

Unknown

Conditions

Wound Contamination
Chronic Leg Ulcer
Wound

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a chronic wound and are receiving standard wound care treatment. The MolecuLight i:X imaging device will be used by the study clinician as an adjunctive tool in the assessment of the wound and will be used to guide the targeted sampling of a wound (with curettage scraping), as per current standard of care in the principal investigator's wound care clinic. The acquired tissue sample will then be analysed using conventional gold standard semi-quantitative culture methods to determine bacterial species present, also as per current standard of care in this clinic.

Enrollment

65 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female patients presenting with a chronic wound (wound duration > 4 weeks) e.g. diabetic foot ulcer, venous leg ulcer, pressure ulcer, or other acceptable aetiology
  2. 18 years or older

Exclusion criteria

  1. Treatment with an investigational drug within 1 month before study enrolment
  2. Inability to consent to medical photography (i.e. inability to understand consent process)
  3. Any contra-indication to routine wound care and/or monitoring
  4. Prior participation of the patient in this study (for the same wound or a different wound).

Trial design

65 participants in 1 patient group

All Subjects
Description:
All subjects in this study will have their wounds imaged and assessed in the following manner: Capture and save ST-image Capture and save FL-image Identify discrete locations of cyan (blue/green) fluorescent bacteria (FL_C) Acquire sample of tissue where cyan fluorescent bacteria are present (using curette method) Consent patient for inclusion in this study Note location of sample acquisition by annotating FL-image obtained in step 2 Send sample for microbiology analysis Note naming of microbiology sample on Case Report Form

Trial contacts and locations

1

Loading...

Central trial contact

Rose Raizman; Liis Teene

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems